Complex TAB*:TAK1*:TGFBR1:TGFBR2 map
Complex composition:

  1. TAB* map
  2. TAK1* map
  3. TGFBR1 map
  4. TGFBR2 map


TAB*:​TAK1*|​pho:​TGFBR1:​TGFBR2@Cytoplasm

Identifiers
NAME:TAB*:TAK1*:TGFBR1:TGFBR2

References
su_mpk1_mpk1_re130( Survival  map ):
Activated TGFBR1/TGFBR2 complex attracts the TAB2/TAB3 proteins which promote activation of TAK1 (by phosphorylation).
TAB1 is an essential cofactor required for activation of TAK1 by upstream stimuli. Endogenous TAK1 is activated by TGF-beta IL-1 and TNF.
PMID:20060931 PMID:11274345
su_mpk1_mpk1_re153( Survival  map ):
MLK3 and MLK2 two MAP3Ks of JNK pathway can interact with RAC1 in a GTP-dependent manner.
MEKK2 and MEKK3 can activate JNK P38 and ERK pathways.
TAO kinases are novel MAP3Ks that specifically regulate P38s.
ASK1 is a MAP3K and can activate both JNK and P38 pathways.
MEKK1 selectively activates the endogenous JNK pathway. MEKK1 can activate MEK4 and MEK7 in vivo.
MEKK4 is a MAP3K and can activate both JNK and P38 pathways.
TAK1 is a MAP3K. It is able to activate both JNK and P38 pathways.
Endogenous TAK1 is activated by TGF-beta IL-1 and TNF. TAK1 can phosphorylate and activate MEK4 MEK3 and MEK6.
MLK3 has the potential to positively regulate the ERK / MAPK  map pathway by directly phosphorylating and activating MEK.
Expression of GADD45 genes in mammalian cells strongly activates co-expressed MTK1 as well as P38 and JNK the MAPKs downstream of MTK1. TAO kinases are MAP3Ks that function upstream of P38 and JNK.
PMID:11274345 PMID:12738796 PMID:18855897 PMID:21614932


Modifications:
Participates in complexes:
In compartment: Cytoplasm
  1. TAB*:​TAK1*|​pho:​TGFBR1:​TGFBR2@Cytoplasm map
Participates in reactions:
As Reactant or Product:
  1. TAK1*@Cytoplasm map + TAB*:​TGFBR1:​TGFBR2@Plasma Membrane map map TAB*:​TAK1*|​pho:​TGFBR1:​TGFBR2@Cytoplasm map
As Catalyser:
  1. MAP2K4@Cytoplasm map map MAP2K4|​pho|​pho@Cytoplasm map
  2. MAP2K6@Cytoplasm map map MAP2K6|​pho|​pho@Cytoplasm map